Analytical Data
-
基因名
PPAN
- Application
-
别名
Brix domain-containing protein 3;Peter Pan homolog
-
种属
Human
-
表达系统
Yeast
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NQ55
-
表达区间
1-473aa
-
分子量
55.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PPAN (Poly(A)-binding Protein, Interacting Protein) is a protein of significant interest in molecular biology due to its pivotal role in various cellular processes, including mRNA processing, stability, and translation. Research on PPAN has gained momentum as its interactions with the Poly(A)-binding protein (PABP) and other RNA-binding proteins highlight its influence on gene expression regulation. The involvement of PPAN in critical cellular pathways, such as the cell cycle and response to stress, has been linked to various diseases, including cancer and neurodegenerative disorders. Understanding the structural and functional properties of PPAN is essential for elucidating its mechanisms in post-transcriptional regulation. Recent advancements in recombinant protein technology have enabled the production and study of PPAN in vitro, facilitating the exploration of its binding affinities and functional dynamics. Furthermore, by investigating the reconstitution of PPAN with RNA and other associated factors, researchers aim to delineate its role in ribonucleoprotein complex formation and its overall contribution to the cellular RNA landscape. This body of research not only enhances our understanding of PPAN but also holds potential for identifying novel therapeutic targets that could modulate its activity in disease contexts. As such, the study of PPAN and its recombinant forms is a promising frontier in cellular molecular biology and therapeutic development.
